Oral administration of recombinant adeno-associated virus elicits human immunodeficiency virus-specific immune responses.

Source:http://linkedlifedata.com/resource/pubmed/id/12228012

Hum. Gene Ther. 2002 Sep 1 13 13 1571-81

Download in:

View as

Triples

General Info

PMID
12228012